Charles David Blanke MD

Professor, Medicine, OR Hlth Sci Univ Sch of Med

3181 SW Sam Jackson Park Rd# L586Portland, OR 97239
Phone+1 503-494-1556
Fax+1 503-494-3257

Dr. Blanke is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Blanke's full profile Already have an account?

Summary

Charles Blanke, MD, is an experienced end-of-life physician based in Portland, OR. Specializing in Medical Aid in Dying or MAID, and Voluntary Stopping of Eating or Drinking (VSED) he has an extensive education, including medical schooling at Northwestern University The Feinberg School of Medicine and a fellowship at Indiana University School of Medicine. He has specific expertise in the operationalization of MAID, including non-resident patients. Dr. Blanke has conducted practice changing clinical trials focusing mostly on gastrointestinal stromal tumors and metastatic colorectal cancer. He has a solid publication record, featuring in esteemed journals like Cancer and Clinical Cancer Research. Recognized for his contributions to healthcare, Dr. Blanke received the 'Who's Who in Medicine and Healthcare' honor from Marquis Who's Who.

Education & Training

Indiana University School of MedicineFellowship, Hematology and Medical Oncology, 1991 - 1994
Gundersen Lutheran Medical FoundationResidency, Internal Medicine, 1988 - 1991
Northwestern University The Feinberg School of MedicineClass of 1988

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

OR State Medical License 1998 - 2027
WA State Medical License 2022 - 2026
TN State Medical License 1994 - 1999
WI State Medical License 1989 - 1991
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2015-2017
CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2015-2017
Whos Who in Medicine and Healthcare Marquis Whos Who

Clinical Trials

Combination Chemotherapy and Bevacizumab in Treating Patients With Locally Advanced, Metastatic, or Recurrent Colorectal Cancer
TERMINATED
PHASE3
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
TERMINATED
PHASE2
Calcitriol and Docetaxel in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer
COMPLETED
PHASE2

Publications & Presentations

PubMed

COMMIT: A Randomized Study of mFOLFOX6/Bevacizumab/Atezolizumab or Atezolizumab Alone as First-Line Treatment of Deficient DNA Mismatch Repair Metastatic Colorectal Ca...
Caio Max Sao Pedro Rocha Lima, Greg Yothers, Thomas J George, Howard S Hochster, Hanna K Sanoff
Journal of Clinical Oncology. 2026-07-29
1 citations
PROSPECT-LUNG: A National Clinical Trials Network Trial Advancing Pragmatic Innovation in Cancer Clinical Trials.
Allison Booth, Shauna Hillman, Kristina Laumann, Ying-Qi Zhao, Michael LeBlanc
Journal of Thoracic Oncology. 2026-07-01
A phase II basket trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART) SWOG S1609: vaginal cancer sub cohort results.
Young Kwang Chae, Josie Czeskleba, Sandip Pravin Patel, Alex Mentor, William Robinson
Journal of Gynecologic Oncology. 2026-03-25

Journal Articles

Association of Diet Quality with Survival Among People with Metastatic Colorectal Cancer in the Cancer and Leukemia B and Southwest Oncology Group 80405 Trial
Kimmie Ng, Chloe Atreya, Howard S Hochster, James N Atkins, Richard M Goldberg, Charles D Blanke, Jeffrey A Meyerhardt, JAMA Network Open
Association of Coffee Intake with Survival in Patients with Advanced or Metastatic Colorectal Cancer
I-Wen Chang, Charles D Blanke, Alan P Venook, Richard M Goldberg, Jeffrey A Meyerhardt, Kimmie Ng, JAMA Oncology
Words Matter: Restoring Respect and Dignity When Referring to Individuals with Cancer
Lee M Ellis, Charles D Blanke, Cancer

Authored Content

Association of the Coronavirus Disease 2019 (COVID-19) Outbreak with Enrollment in Cancer Clinical TrialsJune 2020

Press Mentions

Cancer Cooperative Group Leaders Propose a Re-Engineering of the Nation’s Correlative Science Program for CancerSeptember 18th, 2024
Traveling to Die: The Latest Form of Medical TourismAugust 20th, 2024
SWOG S2302 Pragmatica-Lung Study Opens to Enrollment, a Model for Easier, More Representative Clinical TrialsApril 12th, 2023